Adcock Ingram Holdings Limited (AIHLF) Research

Adcock Ingram Holdings Limited operates as a global healthcare enterprise, engaged in the production, promotion, and distribution of a diverse array of medical and wellness products. Its geographical footprint extends across South Africa, North America (including the United States and Canada), the United Kingdom, other European countries, and various international territories. The company's comprehensive product lineup features non-prescription (over-the-counter) medications, prescribed pharmaceuticals, consumer health goods, as well as medical instrumentation and surgical provisions. Adcock Ingram also provides an extensive selection of specialized pharmaceutical offerings, addressing areas such as women's health, cannabidiol (CBD) oil, antiretroviral treatments, dermatological conditions, central nervous system ailments, respiratory issues, ophthalmology, generic drugs, cardiovascular health, pain management, gastroenterological remedies, energy boosters, cold and flu relief, personal care essentials, feminine hygiene products, digestive health aids, allergy solutions, baby care items, cough syrups, and a variety of food, nutrition, vitamin, and mineral supplements. Additionally, it manufactures and supplies vital hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection apparatus. The company caters to both private healthcare organizations and public sector entities. Established in 1890, Adcock Ingram Holdings Limited is headquartered in Midrand, South Africa.

Open Adcock Ingram Holdings Limited (AIHLF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.